HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells

FEBS Letters

Volumn 587, Issue 16, 2013, Pages 2530-2535

  Tong, Ying ^a   Li, Qi Gen ^a   Xing, Tian Yu ^a   Zhang, Ming ^a   Zhang, Jian Jun ^a   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemoresistance; HIF 1; HIPK2; Hypoxia; WSB 1

Indexed keywords

ETOPOSIDE; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; HYPOXIA INDUCIBLE FACTOR 1; LUCIFERASE; PROTEIN WSB 1; SUPPRESSOR OF CYTOKINE SIGNALING; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL HYPOXIA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG RESISTANCE; GENE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; UPREGULATION; WESTERN BLOTTING; WSB 1 GENE;

CHEMORESISTANCE; HIF-1; HIPK2; HYPOXIA; WSB-1;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CARRIER PROTEINS; CELL HYPOXIA; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84881480420     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.06.017     Document Type: Article

References (21)

1. S.J. Thompson, L.T. Loftus, M.D. Ashley, and R. Meller Ubiquitin-proteasome system as a modulator of cell fate Curr. Opin. Pharmacol. 8 2008 90 95
2. F. Kriegenburg, L. Ellgaard, and R. Hartmann-Petersen Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation FEBS J. 279 2012 532 542
3. E.M. Linossi, and S.E. Nicholson The SOCS box-adapting proteins for ubiquitination and proteasomal degradation IUBMB Life 64 2012 316 323
4. M.J. Emanuele, A.E. Elia, Q. Xu, C.R. Thoma, and L. Izhar Global identification of modular cullin-RING ligase substrates Cell 147 2011 459 474
5. J. Piessevaux, D. Lavens, F. Peelman, and J. Tavernier The many faces of the SOCS box Cytokine Growth Factor Rev. 19 2008 371 381
6. F. Okumura, M. Matsuzaki, K. Nakatsukasa, and T. Kamura The role of Elongin BC-containing ubiquitin ligases Front. Oncol. 2 2012 10
7. T. Kamura, K. Maenaka, S. Kotoshiba, M. Matsumoto, and D. Kohda VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases Genes Dev. 18 2004 3055 3065
8. S.J. Erkeland, L.H. Aarts, M. Irandoust, O. Roovers, and A. Klomp Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation and differentiation signaling Oncogene 26 2007 1985 1994
9. T. Kamura, D. Burian, Q. Yan, S.L. Schmidt, and W.S. Lane Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase J Biol Chem 276 2001 29748 29753
10. D.W. Choi, Y.M. Seo, E.A. Kim, K.S. Sung, and J.W. Ahn Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1 J. Biol. Chem. 283 2008 4682 4689
11. T.G. Hofmann, C. Glas, and N. Bitomsky HIPK2: a tumour suppressor that controls DNA damage-induced cell fate and cytokinesis BioEssays 35 2013 55 64
12. J. Moehlenbrink, N. Bitomsky, and T.G. Hofmann Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation Cancer Lett. 292 2010 119 124
13. W.R. Wilson, and M.P. Hay Targeting hypoxia in cancer therapy Nat. Rev. Cancer 11 2011 393 410
14. M.R. Horsman, L.S. Mortensen, J.B. Petersen, M. Busk, and J. Overgaard Imaging hypoxia to improve radiotherapy outcome Nat. Rev. Clin. Oncol. 9 2012 674 687
15. J. Chen, M. Kobayashi, S. Darmanin, Y. Qiao, and C. Gully Pim-1 plays a pivotal role in hypoxia-induced chemoresistance Oncogene 28 2009 2581 2592
16. E. Monti, and M.B. Gariboldi HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention Curr. Mol. Pharmacol. 4 2011 62 77
17. L. Flamant, E. Roegiers, M. Pierre, A. Hayez, and C. Sterpin TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells BMC Cancer 12 2012 391
18. L. Liu, X. Ning, L. Sun, H. Zhang, and Y. Shi Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer Cancer Sci. 99 2008 121 128
19. P. Maxwell, and K. Salnikow HIF-1: an oxygen and metal responsive transcription factor Cancer Biol. Ther. 3 2004 29 35
20. S.Y. Kim, D.W. Choi, E.A. Kim, and C.Y. Choi Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1 Cancer Lett. 279 2009 177 184
21. M. Winter, D. Sombroek, I. Dauth, J. Moehlenbrink, and K. Scheuermann Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR Nat. Cell Biol. 10 2008 812 824